INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 114 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2018. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $1,000 | 0.0% | 200 | 0.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 200 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $2,000 | -33.3% | 200 | -47.4% | 0.00% | 0.0% |
Q3 2017 | $3,000 | -100.0% | 380 | -51.3% | 0.00% | -50.0% |
Q2 2017 | $10,000,000 | -50.0% | 780 | -56.2% | 0.00% | -66.7% |
Q1 2017 | $20,000,000 | +17.6% | 1,780 | -1.9% | 0.01% | +100.0% |
Q4 2016 | $17,000,000 | +80852.4% | 1,815 | 0.0% | 0.00% | -25.0% |
Q3 2016 | $21,000 | +950.0% | 1,815 | +908.3% | 0.00% | +300.0% |
Q2 2016 | $2,000 | 0.0% | 180 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $2,000 | -60.0% | 180 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $5,000 | 0.0% | 180 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $5,000 | -16.7% | 180 | 0.0% | 0.00% | 0.0% |
Q2 2015 | $6,000 | +20.0% | 180 | +100.0% | 0.00% | 0.0% |
Q1 2015 | $5,000 | +25.0% | 90 | 0.0% | 0.00% | +100.0% |
Q4 2014 | $4,000 | +33.3% | 90 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $3,000 | 0.0% | 90 | 0.0% | 0.00% | -50.0% |
Q2 2014 | $3,000 | – | 90 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 5,406,844 | $52,014,000 | 0.66% |
ETF MANAGERS GROUP, LLC | 282,268 | $3,255,000 | 0.24% |
Mirae Asset Global Investments Co., Ltd. | 1,470,996 | $14,151,000 | 0.19% |
Financial Gravity Companies, Inc. | 4,467 | $42,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 67,200 | $646,000 | 0.04% |
TCI Wealth Advisors, Inc. | 7,766 | $75,000 | 0.03% |
Freedom Investment Management, Inc. | 64,741 | $623,000 | 0.03% |
GAM Holding AG | 83,940 | $808,000 | 0.02% |
SFMG, LLC | 11,994 | $115,000 | 0.02% |
SHELL ASSET MANAGEMENT CO | 95,127 | $915,000 | 0.02% |